Drug intelligence / Profile preview

glossogyne tenuifolia

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Glossogyne tenuifolia is a perennial herb native to Taiwan and widely used in Traditional Chinese Medicine (TCM), where it is known as hsiang-ju or xiang-ru. Traditionally, it has been employed as an antipyretic (fever-reducing), anti-inflammatory, and hepatoprotective agent. Modern pharmacological studies have demonstrated that extracts of Glossogyne tenuifolia possess significant antioxidant, anti-inflammatory, antiviral (notably against hepatitis B virus), hypoglycemic, and vascular protective activities. The main bioactive constituents include luteolin-7-glucoside and luteolin. Mechanistically, the herb inhibits inflammatory mediator release by suppressing cytokines such as TNF-alpha, IL-6, and IFN-gamma; scavenges reactive oxygen species; inhibits LDL oxidation; blocks NF-kappaB and MAPK signaling pathways; reduces proliferation/migration of vascular smooth muscle cells via downregulation of MMPs; inhibits α-glucosidase activity relevant to diabetes management; and demonstrates hepatoprotective effects[1][3][5][6][7]. Its multi-targeted actions are believed to underlie its traditional uses for fever reduction, liver protection, metabolic syndrome support (including type 2 diabetes), cardiovascular health (antiatherosclerotic effects), and inflammation control.

Other names
hsiang-juxiang-ru
02

Targets

HBsAg (Hepatitis B surface antigen)IFNG (Interferon gamma)IL-6 (Interleukin 6)MAPK3 (Mitogen-activated protein kinase 1)MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)NF-κBTNFA (Tumor necrosis factor alpha (soluble))Sucrase-IsomaltaseMEK

Beyond the preview

Go deeper on glossogyne tenuifolia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glossogyne tenuifolia.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call